204
Views
5
CrossRef citations to date
0
Altmetric
Pharmacotherapy

Concomitant Asthma Medication Use by Patients Receiving Omalizumab 2003–2008

, M.D., M.S.H.S., , Ph.D., M.P.H., , Ph.D. & , M.D., M.B.A.
Pages 1058-1062 | Published online: 18 Nov 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Patrick W. Sullivan, Jonathan D. Campbell, Vahram H. Ghushchyan, Gary Globe, Jeff Lange & J. Michael Woolley. (2015) Characterizing the severe asthma population in the United States: claims-based analysis of three treatment cohorts in the year prior to treatment escalation. Journal of Asthma 52:7, pages 669-680.
Read now
Angeliki Zarkali, Drosos E. Karageorgopoulos, Petros I. Rafailidis & Matthew E. Falagas. (2014) Frequency of the off-label use of monoclonal antibodies in clinical practice: a systematic review of the literature. Current Medical Research and Opinion 30:3, pages 471-480.
Read now

Articles from other publishers (3)

Eugene R. Bleecker, Andrew N. Menzies-Gow, David B. Price, Arnaud Bourdin, Stephen Sweet, Amber L. Martin, Marianna Alacqua & Trung N. Tran. (2020) Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management. American Journal of Respiratory and Critical Care Medicine 201:3, pages 276-293.
Crossref
Izabela Kupryś-Lipińska, Paweł Majak, Joanna Molinska & Piotr Kuna. (2016) Effectiveness of the Polish program for the treatment of severe allergic asthma with omalizumab: a single-center experience. BMC Pulmonary Medicine 16:1.
Crossref
Patrick W. Sullivan, Jonathan D. Campbell, Vahram H. Ghushchyan & Gary Globe. (2015) Outcomes before and after treatment escalation to Global Initiative for Asthma steps 4 and 5 in severe asthma. Annals of Allergy, Asthma & Immunology 114:6, pages 462-469.e6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.